Title: Low Voltage-Directed Catheter Ablation for Atrial Fibrillation (LD-CAF)
- Principal Investigator: Dr. Nikhil Panda
- Study Coordinator: Maureen Dempsey
This is a prospective, multi-center, randomized study comparing the protocol specified ablation approach to the current standardized ablation approach in the treatment of non-paroxysmal atrial fibrillation. The purpose is to evaluate long term success of non-paroxysmal atrial fibrillation ablation when using a 1) specified low voltage-directed catheter ablation with pulmonary vein isolation (LD +PVI) approach compared to 2) pulmonary vein isolation (PVI) alone.
This study is administered by VREF and funded by the MetroHealth System; Biosense Webster, Inc.
Find Out More
This study is actively enrolling patients. To learn more about LD-CAF and how you can join contact our research office at (314) 289-7690.
If you are a veteran receiving care through the VA St. Louis Health Care System and believe you may be eligible for this study, please speak with your Physician. For general information about our research, please visit our main Clinical Trials page or contact us directly.